Adam Teichman, DPM
Foot & Ankle Surgery · Allentown, PANPI 1043203656
Payments from drug & device makers
Across 1,156 payments — averaging $471.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organogenesis Inc.$224K
- Averitas Pharma Inc.$177K
- GRT US Holding, Inc.$132K
- Stryker$4K
- Amgen$2K
- Convatec Inc.$2K
- plus $4K from 31 others
What the payments were for
- Consulting fees$53,97210%
- Speaking & faculty fees$369,40668%
- Travel & lodging$98,47418%
- Food & beverage$22,7254%
- Entertainment$160%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organogenesis Inc. | 456 | $223,860 |
| Averitas Pharma Inc. | 244 | $177,360 |
| GRT US Holding, Inc. | 183 | $132,105 |
| Stryker | 44 | $3,694 |
| Amgen | 73 | $1,848 |
| Convatec Inc. | 20 | $1,695 |
| Smith+Nephew | 51 | $1,460 |
| Nevro Corp. | 16 | $426 |
| Next Science LLC | 4 | $392 |
| Reapplix Inc. | 12 | $346 |
| Paratek Pharmaceuticals, Inc. | 12 | $175 |
| Kerecis Limited | 3 | $163 |
| Globus Medical | 9 | $156 |
| Stability Biologics, LLC | 1 | $135 |
| Treace Medical Concepts, Inc. | 1 | $120 |
| Zimmer Biomet | 1 | $59 |
| Misonix Inc | 1 | $57 |
| Novus Surgical Solutions LLC | 1 | $55 |
| Musculoskeletal Transplant Foundation Inc. | 3 | $54 |
| Melinta Therapeutics, LLC | 2 | $42 |
| Axogen | 1 | $40 |
| Boston Scientific | 1 | $39 |
| Cashflow Solutions, LLC | 1 | $39 |
| Johnson & Johnson | 2 | $39 |
| KCI USA, Inc. | 2 | $36 |
| IBSA Pharma Inc. | 1 | $24 |
| Vertex | 1 | $24 |
| Reddress USA, Inc. | 1 | $24 |
| Urgo Medical North America, LLC | 1 | $20 |
| Kowa Pharmaceuticals America, Inc. | 1 | $18 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $18 |
| Bone Support Inc. | 1 | $14 |
| Merck | 1 | $13 |
| Electronic Waveform Lab, Inc. | 1 | $13 |
| Synergy Orthopedics, LLC | 1 | $12 |
| ERMI LLC | 1 | $10 |
| Orthofix Medical, Inc. | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Qutenza$304,074
- PuraPly$66,456
- Apligraf$64,971
- Dermagraft$55,607
- Puraply/Affinity/NuTech$55,607
- Puraply Antimicrobial$37,669
- Affinity$32,162
- PURAPLY WOUND MATRIX$17,740
- RAYOS$3,210
- NuShield$1,615
- NOVACHOR$1,440
- InnovaMatrix AC$1,200
- AUGMENT INJECTABLE$1,106
- INFINITY$556
- GRAFIX PL$431
- VARIAX$404
- Stravix$293
- ORTHOLOC 2 LAPIFUSE$289
- ALLOWRAP$264
- Xperience$234
How this compares
$544,593 in reported general payments places this provider in the 95th percentile of 575 foot & ankle surgery providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| QutenzaCapsaicin/Skin Cleanser | 21 | $76,774 |
| SantylCollagenase Clostridium Hist. | 13 | $7,516 |
| Lidocaine | 21 | $4,601 |
| Ammonium Lactate | 18 | $367 |
| Diclofenac Sodium | 18 | $345 |
| Ciclopirox | 20 | $211 |
| Doxycycline Hyclate | 25 | $195 |
| Methylprednisolone | 37 | $164 |
| Gabapentin | 29 | $158 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 13 | $95 |
| Meloxicam | 28 | $79 |
| Mupirocin | 11 | $75 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GRT US Holding, Inc.Qutenza | $132,105 | $76,77421 claims |
| Smith+NephewSantyl | $1,460 | $7,51613 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 575 foot & ankle surgery providers in Pennsylvania.
Other foot & ankle surgery in Allentown
- Thomas RocchioAllentown$524K
- Elliot BuschAllentown$30K
- William DecarboBelle Vernon$3.5M
- David PedowitzBryn Mawr$1.7M
- Noman SiddiquiScranton$1.3M
- Peter MangonePittsburgh$1.1M
- Stephen BrigidoBethlehem$656K
- Guido LaportaDunmore$625K
- Jason MillerMalvern$551K
- James SferraCranberry Township$457K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.